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IN 1959 an artificial kidney service for Northern Ireland was commenced
in the Belfast City Hospital. The original intention was to treat only
temporary renal failure, but inevitably patients were referred with other
types of kidney disease, and it became necessary to attempt to provide
treatment for end-stage renal failure. During the seven year period
1962-1968 seventeen patients were treated by short periods of main-
tenance haemodialysis, then sent for kidney transplant to the few centres
in Great Britain then engaged in kidney transplantation. In 1968 financial
provision was made for the treatment of chronic renal failure by hospital
haemodialysis and kidney transplantation, two beds being provided for
regular dialysis. A ten bed unit for regular dialysis was brought into
operation in 1971. The first kidney transplant was carried out in
November 1968 and the hundredth transnlant in November 1976.
PATIENTS AND METHODS
During the early years when regular dialysis treatment was greatly
restricted, patients could be accepted only when a space occurred as the
result of a transplant or death, even if they were suitable in all respects.
Later when the ten bed unit was ready for use, patients without medical
contra-indication were accepted between ages 15 and 50. Patients with a
history of myocardial infarction, cerebro-vascular accident, multi-system
disease such as diabetes mellitus or systemic lupus, severe disease
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81unrelated to the renal disease or known mental instability were excluded.
Hypertension, left ventricular failure and pericarditis were considered
acceptable complications. Often perfectly suitable young patients could
not be accepted because no places were available. Similarly at other times
patients somewhat older than 50 were accepted because a space existed
at the time they needed it. The age range of patients receiving transplants
was 13 to 53; 34 were between the ages of 15 and 34, 24 between the ages
of 35 and 40, 25 between the ages of 41 and 49, and 7 aged 50 or over, at
the time of the first graft.
Ninety-one patients received the 100 kidney transplants, there being
seven second transplants and two third transplants. The commonest
primary renal diseases leading to terminal renal failure were glomerulo-
nephritis (48 per cent), chronic pyelonephritis (18 per cent), polycystic
disease (16 per cent) and hypoplastic kidneys (5 per cent).
PREPARATION FOR TRANSPLANTATION
Once accepted for the programme, the patients were informed as fully
as possible of the details of the treatment planned for them. Whenever
possible an arterio-venous fistula was prepared in advance of need,
usually when serious restriction of dietary protein was commenced.
Patients referred when already in terminal failure were maintained by
regular peritoneal dialysis until a fistula could be prepared and developed
ready for use. Peritoneal dialysis was also used as a temporary measure
for patients already accepted who reached the terminal stage when the
programme was full. Patients were transplanted either after hospital
haemodialysis or occasionally after hospital peritoneal haemodialysis;
only one patient was transplanted following home haemodialysis. One
patient, the youngest, aged 13, received a transplant from his mother
just in advance of actual terminal renal failure.
The general aim was to restore the patients to a reasonable state of
health and nutrition before considering transplantation. A few patients
had a kidney transplant while still very unfit and still being treated by
peritoneal dialysis, either because the haemodialysis programme was full
or because a satisfactory arteriovenous fistula could not be made. Ten
patients received peritoneal dialysis only. The median time on dialysis
was nine months, 47 patients receiving a kidney graft in nine or more
months, and 44 in less than nine months. Nine patients waited longer
than two years on dialysis.
The patients received 14 hour haemodialysis twice a week on KiiI
kidneys or capillary kidneys, using a single pass system either from a
batch tank or a Dylade. For a six month period during an outbreak of
HBs Ag hepatitis in 1971, all haemodialysis was on disposable flat plate
or capillary kidneys. Dialysers were not reused in hospital dialysis.
Patients treated with peritoneal dialysis received 30 one litre exchanges
twice weekly.
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were established on dialysis but after this the diet contained 60 g protein,
the sodium intake being prescribed according to the difficulty experienced
in the control of hypertension, and the potassium intake, according to
pre-dialysis level of plasma potassium varied from 50 to 70 mmol/day.
Orovite tablets were prescribed for all patients. A few patients required
methyldopa and/or clonidine for hypertension not controlled by dialysis.
Even after bilateral nephrectomy a few continued to require these hypo-
tensive drugs, although in smaller dosage. Since 1973 patients with low
plasma iron receive oral iron, and prior to that some received intravenous
iron total dose infusion. Considerable quantities of diazepam (Valium)
were prescribed during the earlier years, but the consumption of this
became less after the conclusion of a psychiatric study of the patients.
Nitrazepam (Mogadon) was taken for night sedation by many of the
patients, although flurazepam (Dalmane) displaced it for a short time.
Later the patients were advised to avoid flurazepam because of a cerebral
syndrome possibly related to its use. Patients with hypocalcaemia were
treated with calciferol or dihydrotachysterol, some also received alu-
minium hydroxide-none developed any evidence of dialysis dementia.
Persistent hypercalcaemia unrelated to these drugs was treated by sub-
total parathyroidectomy in a few patients.
All the patients had a micturating cystogram to determine adequacy of
bladder capacity and bladder emptying and the presence or absence of
reflux. All patients had a barium meal but more recently bleeding
occurring during dialysis from duodenal ulcers not shown on the barium
meal has led us to do a more detailed study of gastric function (Doherty,
O'Connor, Buchanan, Douglas, McGeown, 1977). One patient required
vagotomy and later a subtotal gastrectomy for bleeding from recurrent
ulceration.
Bilateral nephrectomy was carried out almost routinely until the end
of 1975, 65 out of 76 patients undergoing removal of their kidneys prior
to transplantation. In another patient the kidneys were removed after
the transplant because of severe hypertension. In 1976, because of severe
hypertension not satisfactorily controlled by dialysis, or because of poly-
cystic disease, seven of 16 patients underwent bilateral nephrectomy.
The bilateral nephrectomy was carried out as a one stage operation
through a single incision except in patients with bilateral polycystic
kidneys. In one patient with polycystic disease, a very large kidney was
removed on one side, the other being left. The thymus was not removed
in any patient, and the spleen in only one, when it had been damaged
inadvertently during the bilateral nephrectomy.
As the patients were to have a major operation at short notice when a
kidney became available, it was thought unwise to allow the packed cell
volume to fall below 15 per cent, and a liberal policy as regards blood
transfusion was followed compared with most units. Only six patients
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undergone bilateral nephrectomy no doubt increased the need for blood
transfusion.
Tissue typing was carried out, using a standard lymphocyte toxicity
method. Seven transplants were carried out before the tissue typing
service was established and these grafts were given on the basis of ABC
match only. The donor tissue type was known and was used to select the
best matched recipient for the other 93 transplants. The direct cross-
match was negative in all except one patient where the cross-match was
not carried out because the kidney was received without a lymph node.
The result of the cross-match was not known until the operation was
under way, for the 58 patients who received an imported kidney.
DONORS
Ninety-six cadaver and four live donor grafts were carried out. One
patient received a kidney from his identical twin (Nevin and McEvoy,
1973) and three patients received a kidney from a parent. Thirty-eight
of the cadaver kidneys were from local donors, the initial warm
ischaemia time varying from 15 to 80 minutes, two patients receiving
kidneys with a warm ischaemia time of 70 minutes and one of 80
minutes. The warm ischaemia time was generally shorter for kidneys
received from other centres but, in all, 18 kidneys with warm ischaemia
of 50 minutes or more were used.
The total ischaemia time varied from 159 to 855 minutes. The longest
total ischaemia time (805 and 855 minutes) were associated with long-
term good function. Drugs werc not given to local donors as preparation
for transplantation but nine had already received Decadron, one mannitol
and seven antibiotics. Some of the donor kidneys from other centres had
received pre-treatment with various drugs including heparin, phenoxy-
benzamine, dibenyline, rheomacrodex and frusemide.
TECHNIQUE OF REMOVAL OF DONOR KIDNEYS
Ante-mortem assessment of the donor's physiological status was carried
out by a senior member of the team in all of our kidney retrieval pro-
cedures. Very critical attention was paid to the general vital signs such as
peripheral capillary circulation, urinary output, blood urea and creatinine
levels and blood pressure in the period before demise. Whilst beating
heart donor retrieval was not practised, the timing for retrieval was
carefully judged to provide as "vital" tissue as possible.
Depending on the anatomical chest/abdominal configuration, either a
total midline exposure or curved upper abdominal incision was used.
Meticulous dissection to find polar vessels was performed but no on-block
renal removals were carried out. Care was taken to prevent traction on
the renal pedicle to avoid circular intimal tears which had been noted in
two imported kidneys.
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obtained a good organ for transplantation-a five star perfusion being
noted as being a solid flow in the drip chamber. The local kidneys were
perfused manually and the solutions used were fructose/bicarbonate,
Gelin's solution or Perfudex. The majority of kidneys received from other
centres were perfused with Perfudex.
TRANSPLANT OPERATION
The transplant operation was a standard iliac fossa extra-peritoneal
insertion. After wide and thorough surgical toilet, a urethral catheter was
passed and bladder irrigation carried out with 2 per cent Neomycin
solution, usually about 150 ml of this solution being left in the bladder
to facilitate lateral wall vesical dissection. Peri-vascular lymphatic dis-
section was carried out with 90 linen ligature of the tissues to avoid
lymphoceles.
In the majority of cases the renal vein was anastomosed to the external
iliac as end to side, using 5/0 ethiflex. Particular attention was paid in the
siting of the venotomy in the recipient vessel to produce a "coned out"
open anastomosis at the venostomy. Arterial reconstitution is now
practised as end to side anastomosis, using 6/0 ethiflex after a sharp
linear arteriotomy is done on the recipient vessel. On two occasions,
arterial bench surgery was required to join a large polar vessel to the
main renal artery.
At all times very careful attention was paid to haemostasis to avoid
post-operative haematomata and infection. Ureteroneocystostomy has
been carried out by two techniques. Cystotomy and a Leadbetter-Politano
mucosal tunnel was initially used, using 4/0 chromic gut without a splint.
Subsequently, vesical myotomy and on-lay direct anastomosis of ureter
to vesical mucosa, using 4/0 chromic gut, was found easier and simpler.
The anastomosis should be placed well down on the side wall of the
bladder. Whilst requiring a meticulous technique, this has the advantage
of placing the asanastomosis in the relatively non-mobile part of the
bladder and at the same time renders future uretogram studies easier if
required.
The wound was always drained by two corrugataed drains. Post-
operatively, six hourly vesical irrigation was continued until the effluent
was pink and the risk of clot retention ceased. Urethral catheters were
usually removed between the fourth and fifth day.
IMMUNOSUPPRESSION AND POST-TRANSPLANT CARE
The patients given living donor grafts, with the exception of the
identical twin, received their first immunosuppression 24 hours before the
transplant. The other 87 patients receiving cadaver kidneys were given
the first immunosuppression as soon as the intravenous infusion was
85commenced in theatre, well before the actual transplant. They were then
given azathioprine 5 mg/kg body weight and hydrocortisone 200 mg
intravenously. The dose of hydrocortisone 200 mg was repeated at six
hour intervals intravenously over the first 24 hours (800 mg in total).
During the second 24 hours azathioprine 1.5 mg/kg body weight and
prednisolone 20 mg were given orally. This treatment was repeated daily
until the creatinine clearance exceeded 20, later 30 ml/min, when the
azathioprine was increased to 3 mg/kg body weight and continued at this
level unless leucopenia occurred. Maintenance treatment was azathioprine
3 mg/kg body weight and prednisolone 20 mg daily. After six months the
dose of prednisolone was reduced gradually to 10 mg daily, this dose
being reached some time during the second year. Patients developing a
Cushingoid appearance were changed to a double dose of prednisolone
given on alternate days.
Rejection episodes were treated by increasing the dose of prednisolone
to 200 mg daily in divided doses reducing in two to five day steps through
150, 100, 75, 50 to 20 mg daily. At first the dose of azathioprine was
doubled for five days and actinomycin C 400 ug was given once intraven-
ously, but this was discontinued after two patients died of sepsis following
treatment of late rejection episodes. Increase in the dose of prednisolone
alone appears to be satisfactory for treatment of rejection, without an
increase in cytotoxic drugs. In a few patients rejection was treated with
an intravenous bolus of methylprednisolone 1 g repeated at 24-48 hour
intervals up to a maximum of four doses, but this method did not appear
to be superior to the previous method.
Considerable care was taken to exclude other causes of a decline in
graft function before making a diagnosis of rejection, especially after
finding that a rising plasma urea and creatinine in two patients were
associated with severe hyperglycaemia rather than rejection (Hill,
Douglas, Rajkumar, McEvoy and McGeown, 1974). Renography has
been found valuable in the early post-transplant period to show that the
graft blood supply is intact, and later to exclude ureteric obstruction,
although care and experience is needed in interpretation (Doherty,
Douglas and McGeown, 1977).
Other tests used at times included urinary osmolality, estimation of
fibrin degradation products (Lameire, Baele, Hilderson and Rengoir,
1973; Hoq, Anderton, Cunningham and Cash, 1974) in urine, excretion
of N-acetyl-beta-D-glucosaminidase (N.A.G.) (Wellwood, Ellis, Hall,
Robinson and Thompson, 1973), the rosette inhibition test (Bach, Dor-
mont, Dardenne and Balner, 1969; Bewick, Ogg, Parsons, Snowden and
Manuel, 1972), the accumulation of radioactive fibrinogen in the graft
(Salaman, 1972; H{oward, Sutherland and Najarian, 1973), and evidence
of increase in graft size by radiographic measurement of metal clips
inserted in the capsule of the graft at both poles. At present rejection is
diagnosed by a combination of clinical features and laboratory tests. The
86laboratory tests most helpful are the plasma urea, serum creatinine,
creatinine clearance, amount of proteinuria, blood sugar level, urinary
excretion of N.A.G. and exclusion of virus infection, in particular
cytomegalic virus infection.
Other aspects of post-transplant care may be of importance. The trans-
plants were carried out in a theatre within the Renal Unit and the
patient was treated throughout the immediate post-operative period in an
area receiving filtered air under controlled pressure, the patient's room
being situated between "clean" and "dirty" corridors. All used and
waste materials and specimens were disposed of via the "dirty" corridor.
Until the bladder catheter and drains were removed and the wound
was completely healed, the patient was isolated as much as possible. Visits
by doctors were reduced to the minimum really necessary and visitors
were not allowed in the patient's room although they could visit freely in
the "dirty" corridor and chat through a polythene panel in the door.
Nursing duties were planned so that the nurses who looked after the
patient had as little contact as possible with other patients within the
unit-which also includes facilities for treatment of patients with acute
renal failure. Daily wound swabs, urine cultures, throat swabs and blood
cultures were taken during the period of strict isolation. Prophylactic
antibiotics and antifungal agents were not used. The use of antibiotics
was sparing, if possible being withheld during episodes of fever until a
positive diagnosis was made by culture.
Daily urea, electrolytes and full blood count with film were taken and
once urine was produced daily serum creatinine and creatinine clearance
were also carried out. Serum alkaline phosphatase was estimated twice
weekly. Elevation of plasma potassium within the first 36 hours of
operation was treated by intravenous infusion of sodium lactate, glucose
and insulin, and later by calcium resonium followed by haemodialvsis
when necessary. During the diuretic phase, sodium and potassium supple-
ments were given as required.
Frusemide was not given during operation or early in the post-
operative period and few patients were given it at any time. Heparin,
rheomacrodex and antilymphocyte serum were never used and local
irradiation of the graft was used once.
After discharge from hospital, usually about three weeks after opera-
tion, the patients were reviewed twice weekly for the first three months,
after which the frequency of attendance was reduced according to whether
problems had been encountered, and during this time the dose of steroid
was reduced as described above. At the beginning of the second year
most patients were seen once every four weeks and at the end of that
year once every eight weeks. Even the "oldest " transplants are reviewed
at 12 week intervals. At each review the patient is weighed, urine is
tested for sugar, etc., a mid-stream urine specimen, serum creatinine and
creatinine clearance, urinary protein, urea and electrolytes and full blood
87count are done. If sugar is detected on routine urine testing, the blood
sugar is estimated. At longer intervals the serum calcium and alkaline
phosphatase are estimated. HBs Ag testing is carried out at frequent
intervals over the first six months. All patients were HBs Ag negative at
the time of the transplant and remain negative.
METHOD OF ANALYSIS
The data on patient and graft survival were analysed by the life-table
method (Cutler and Ederer, 1958) and the cumulative survival rate and
its standard error expressed as percentages. The analysis was completed
for survival of grafts and patients at 31st December 1976.
RESULTS
Table I shows the source of all the grafts. The four kidneys taken from
live donors functioned immediately and three of them continue to func-
TABLE I
Kidney Transplants in Belfast, 1968-1976
Source Number of grafts Number of patients
Identical twin 1 1
Parent to child 3 3
First cadaver graft 87 87
Second cadaver graft 7 7
Third cadaver graft 2 2
Total 100 91
tion well, two for nine months, one (identical twin) for five years. The
remaining patient died, with -excellent graft function, 22 months after the
transplant from a catastrophic haematemesis at home. He had been
treated for rejection three weeks previously, the rejection having been
thought to have been precipitated by failure to take his immunosuppres-
sive drugs during a New Year holiday in Scotland.
Seventy-six patients survive, one of whom has returned to haemo-
dialysis to await a second graft. Two patients died three months after
return to regular haemodialysis. The cumulative patient survival is shown
in Table II and 80.7 per cent survive two years or longer, no deaths
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Months Years
0-3 3-6 6-12 1-2 2-3 3-4 4-5 5-6 6-7 7-8
Patients at risk 91 81 72 64 51 33 21 10 9 3
Deaths 8 3 1 1 2 0 0 0 0 0
Lost to follow-up* 0 0 0 0 0 0 0 0 0 0
Withdrawn alive4 2 6 7 12 16 12 11 1 6 3
Cumulative survival 91.1 87.6 86.2 84.7 80.7 80.7 80.7 80.7 80.7 80.7
(+ S.E.) (S) 3.0 3.5 3.6 3.9 4.6 4.6 4.6 4.6 4.6 4.6
Grafts at risk 100 81 72 63 50 32 22 10 9 3
Failures 13 3 1 0 0 0 0 0 0 0
Lost to follow-up* 4 0 1 1 2 0 0 0 0 0
Withdrawn alive 2 6 7 12 16 10 12 1 6 3
Cumulative survival 86.6 83.3 82.1 82.1 82.1 82.1 82.1 82.1 82.1 82.1
(+ S.E.) (%) 3.5 3.8 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9
First grafts at risk 91 74 66 57 45 30 21 10 9 3
Failures 11 3 1 0 0 0 0 0 0 0
Lost to follow-up* 4 0 1 1 2 0 0 0 0 0
Withdrawn alive 2 5 7 11 13 9 11 1 6 3
Cumulative survival 87.5 83.8 82.5 82.5 82.5 82.5 82.5 82.5 82.5 82.5
(+ S.E.) (%) 3.5 3.9 4.1 4.1 4.1 4.1 4.1 4.1 4.1 4.1
* Died with functioning graft
4 Not yet completed time interval
occurring between three and seven years. Eight of the 15 patients who
died had excellent graft function up to the time of death (Table III)
TABLE III
Causes of death related to kidney transplant
With functioning graft:
Myocardial infarction
Cerebrovascular accident
Cerebral syndrome
Late infection
Haematemesis
Number of patients
3
1
1
2*
1
Without functioning graft:
Death on dialysis, graft rejected
Cerebral syndrome
Stenosis ureter, chest infection
Cerebrovascular accident
2.
1t
I
13
89
Total
* one at three months, one at nine months
t one at one yearand postmortem examination of the transplant showed no evidence of
rejection or other abnormality. The causes of death in these eight
patients were myocardial infarction (3), cerebrovascular accident (1),
cerebral syndrome (1), late chest infection (2), haematemesis (1). Four
died with non-functioning grafts and another patient died soon after
removal of an early rejected graft. This patient and two of the others
died from a peculiar cerebral syndrome, cause unknown; an association
with ingestion of flurazepam, or a combination of flurazepam and diaze-
pam, was suspected but could not be proved (Taclob and Needle, 1976).
One died from a cerebrovascular accident at 10 days post-transplant and
the other patient from unrecognised ureteric obstruction and chest
infection at one year. Infection caused no deaths within the first 60 days
after transplantation although chest infection led to two of the later
deaths, which followed leucopenia due to antirejection therapy including
high dosage (6 mg/kg body weight) of azathioprine and also actinomycin
C. There have been no further deaths from infection since it was decided
to treat rejection episodes with increase in prednisolone without increase
in azathioprine, and actinomycin C was omitted.
TABLE IV
Fate of all cadaver kidney grafts 1968-1976
Number of grafts
Number of grafts functioning
First 87 64
Second 7 5
Third 2 2
Total 96 71 (73.9%)
The fate of all the cadaver grafts in shown in Table IV and overall
73.9 per cent of the grafts survive. Two of the 71 surviving grafts have
poor function after 32 years (serum creatinine 515 and 770 umol/1), one
from recurrence of chronic pyelonephritis in the graft (Hill, Loughridge,
Bharucha and McGeown, 1977), one probably from chronic rejection
although the precise cause is not known. The other 69 grafts have ade-
quate to excellent function. The survival of the small number of second
and third grafts is gratifying, both third grafts surviving. One patient
who received three grafts thrombosed the first two grafts on the third
day, but the third graft continues to operate after more than two years.
A second patient received three grafts; the first was removed at the
primary operation because the middle two-thirds did not become vascu-
larised, the second was rejected at three weeks, and the third continues
to function at over nine months.
90The cumulative survival of all grafts is shown in Table II and is
82.1 per cent (S.E. ±+3.9) from one to seven years.
The cumulative survival of all 91 first transplants (including the four
live donor grafts whose survival does not differ from the cadaver donor
grafts) is shown in Table II. The life table method of calculation makes
an allowance for the eight patients who died with excellent graft function
(Table III). The cumulative survival of first transplants is 82.5 per cent
(S.E. ±4.1) from one to seven years.
TABLE V
Cause of loss of graft
Number of grafts
Rejection 5
Arterial problems 5*
Venous thrombosis 2
Primary non-function 2
Haemorrhage 1
Stenosis of ureter 1
Early death of patient 1
Death with functioning graft 8
Total 25
* Rejection could be excluded in 1 only, although patho-
loqical appearances not typical of rejection in others.
The cause of the loss of graft is shown in Table V. It can be seen that
rejection clearly was responsible for five of the graft failures and may
have contributed to four of the five arterial thromboses although the
pathological appearances were not typically those of rejection. Rejection
was not implicated in the loss of the remaining 16 grafts.
There were 19 first transplants without a mismatch on the B locus and
the cumulative graft survival of the group was 94.6 per cent (S.E. ±5.3)
from three months to seven years. There were 48 first transplants with
one mismatch on the B locus and the cumulative graft survival of this
group was 77.1 per cent (S.E. ±4.3 at three months, 70.7 per cent
(S.E. ±+5.4) at one to seven years. Seventeen first transplants had two
mismatches on the B locus and the cumulative graft survival was 75
per cent (S.E. ±10.8) at three months to seven years. These differences
were not statistically significant (p>0.05).
There were 48 patients of group 0 receiving a first transplant and their
cumulative graft survival was 93.6 per cent (S.E. +3.6) at three months,
88.6 per cent (S.E. +4.8) at one to seven years. Twenty-eight patients of
91group A received a first transplant from a donor of group A and their
cumulative graft survival was 77.4 per cent (S.E. ±8.1) at three months,
69.3 per cent (S.E. ±9.1) at one to seven years. These differences were
not statistically significant (p>0.05).
TABLE VI
Transfusions before first transplant
Number of units Number of Number with
of blood* patients functioning grafts
0 6 3
1 -9 32 29
1 -4 16 14
10+ 31 28
Total 69 60
* Packed cells or whole blood
The number of units of blood given before the first transplant was
known accurately for 69 patients and this is shown together with the fate
of the grafts in Table VI. The small number of patients who did not
receive blood precludes statistical analysis although it appears that first
grafts did less well in these patients than in those who received blood, but
the quantity given does not seem to have affected the outcome.
In patients treated by dialysis for less than nine months the cumulative
function of first transplant was 71.2 per cent (S.E. +5.2) at three months
and 69.0 per cent (S.E. ±5.5) at one year. In patients dialysed for longer
than nine months it was 93.3 per cent (S.E. +3.7) at three months and
85.9 per cent (S.E. ±5.3) at one year. These differences were significant
at three months (p<.Ol) but not at one year (p>0.05).
The 10 patients treated by peritoneal dialysis did not differ significantly
from those treated by haemodialysis as the grafts of eight functioned well
for long periods. Seven of the eight grafts still function while one was
lost on the death of the patient from myocardial infarction at 26 months.
The remaining two grafts were rapidly rejected-it may be of significance
that these two recipients were not transfused.
REHABILITATION
Seventy-four of the 76 remaining patients have been well rehabilitated.
One patient who has returned to haemodialysis to await a second graft is
not fully rehabilitated, and one who was disabled by peripheral neuro-
pathy before haemodialysis remains disabled although living at home and
92capable of caring for personal needs. Two further patients who were
working full-time have ceased to work because of severe angina. One
received his graft at the age of 53, developed venous thrombosis of the
graft after a few weeks, the thrombus was successfully removed (Clarke,
Kennedy, Hewitt, McEvoy, McGeown and Nelson, 1970), underwent
transurethral prostatectomy at the age of 59 and still has a serum
creatinine of 85 umol/l at the age of 61. The second was 46 at the time
of the graft and three years later had a myocardial infarct followed by
persistent angina but his serum creatinine remains unchanged at 280
umol/l after four-and-a-half years. The remaining 72 patients are all
capable of full-time work although not all have been able to find a job
because of the high level of unemployment here.
DISCUSSION
It is generally accepted that the patient with a successful kidney trans-
plant becomes more fit and has a better quality of life than the patient
treated by regular dialysis. The mortality following transplantation is
thought to be considerably higher than that associated with regular
dialysis. Sixty-six of our 91 patients who received a kidney graft survive,
and moreover, eight died with functioning grafts. In four of these the
cause of death (myocardial infarction in three, cardiovascular accident in
one) could not be attributed to the transplant operation, although
attributable to the hypertension and chronic renal failure prior to it. Two
deaths occurred more than three months after removal of the rejected
transplanted kidney. Including all these deaths, the over-all survival of
patients was 83 per cent. The cumulative survival of our patients after
transplantation was 86.2 per cent at one year, 84.7 per cent at two years,
and 80.7 per cent at five years. The most comparable figures are those
reported for Europe by EDTA for patient survival after the first
cadaver graft (Gurland, Brunner, Chantler, Jacobs, Scharer, Selwood,
Spies and Wing, 1976) of 72.8 per cent at one year, 65.8 per cent at two
years and 60.7 per cent at three years. They can also be compared with
the survival figures on home dialysis, which is generally considered to give
the best survival rates, reported by EDTA (Gurland et al., 1976), of 93.1
per cent at one year, 86.7 per cent at two years and 80.8 per cent at three
years, and with those reported by Henari et al (1977) of 91.2 per cent at
one year, 82.6 per cent at two years and 71.5 per cent at five years.
Seventy-four per cent of all the grafts survive. The cumulative survival
of the first graft was 82.1 per cent at one to seven years. The cumulative
survival of first cadaver grafts reported by EDTA was 50.1 per cent at
one year, 43.9 per cent at two years and 39.4 per cent at three years
(Gurland et al., 1976). There were only four living donor grafts in our
series and as their fate was similar to the cadaver grafts, and as their
number was small, it seems reasonable to combine the results.
93Infection is the commonest cause of death following transplantation
(Henari et al., 1977) and accounted for 37.5 per cent of all deaths during
the first 60 days after transplantation in the EDTA series (Gurland et al.,
1976). The low incidence of serious sepsis in our patients after trans-
plantation and the fact that no patient died from sepsis during their
hospital admission for the transplant can mainly be attributed to the
reverse barrier nursing in our specially ventilated unit and the care taken
to follow the strict discipline involved. However, the sparing use of
steroid and the fact that anti-lymphocyte serum was not used may also
have been important. Falling renal function is investigated as a matter of
emergency as it is our policy to prescribe anti-rejection therapy only after
careful exclusion of other causes of falling graft function, and when a
kidney fails to remove it rather than persist too long with high dosage of
steroid. Episodes of fever due to cytomegalic virus infection were the
commonest reason for readmission during the first three months. During
the high fever associated with cytomegalic virus infection the serum urea
and creatinine became elevated in some patients, but this was not a
manifestation of rejection and we feel it should not be treated by
increased dosage of steroid.
Immediate function of the graft was exceptional in the 96 cadaver
kidney grafts, presumably because of the relatively long warm and total
graft ischaemia times. Only one patient received a kidney with zero warm
ischaemia (from a continental donor). The majority of the patients
required one or more haemodialysis (or peritoneal dialyses in patients
previously treated in this way) in the post-operative period. However,
the early period of acute renal failure, even when the initial warm
ischaemia was prolonged, did not adversely affect the future function of
the graft. The three patients who received the kidneys with the longest
warm ischaemia (two of 70, and one of 80 minutes) have excellent func-
tion seven to eight years after the graft was carried out. Eight of the
kidneys which function well had a total ischaemia time of over 720
minutes, and the kidney with the longest total ischaemia of 855 minutes
continues to function well over three years later. White, Evans and Calne
(1968) have also noted that acute renal failure does not prejudice the
future of the graft.
In grafts which functioned during the first 24 hours a fall in urine
volume, associated with swelling of the graft and fever, often occurred on
the third to fourth day. This was probably due to acute tubular necrosis
rather than to rejection, but if it was due to rejection it usually recovered
gradually and spontaneously without anti-rejection therapy.
At first we thought that the degree of fitness of the recipient at the
time of transplant was very important but surprisingly the ten patients
transplanted from peritoneal dialysis, who were in general the least fit,
did not differ from the patients transplanted from haemodialysis as 80
per cent had functioning grafts at one year.
94The frequent use of bilateral nephrectomy may have affected the
results in several ways. There is no doubt that the patients required more
blood transfusions after the nephrectomy and there have been many
recent suggestions that blood transfusion improves graft survival in
patients (Festenstein, Sachs, Paris, Pegrum and Moorehead, 1976; Opelz
and Terasaki, 1976; van Hooff, Kalff and van Poelgeaste, 1976) and in
animals (van Es, Marquet, van Rood, Kalff and Balner, 1977). We have
noted that the incidence of urinary tract infection is lower amongst our
nephrectomised patients (Douglas, Clarke, Kennedy, McEvoy and
McGeown, 1974) than in other series (Hamshere, Chisholm and Shack-
man, 1974; Steen, Pedersen and Vejlsgaard, 1975). The bilateral nephrec-
tomy did not lead to the death of any patient although several developed
troublesome wound infections and two were left with wound hernias.
The exccllent survival of the grafts is not easily explained. Thirty-five
patients received a first transplant with none or one HLA mismatch, and
48 with two or more mismatches, so that in more than half the patients
the match grade was not particularly good. The 19 first transplants with-
out a mismatch on the B locus had a cumulative survival of 94 per cent
S.E. +5.3) compared with a survival of 75 per cent (S.E. ±10.5) in
those with two mismatches on this locus, but the difference was not
statistically significant.
Most of the patients received kidneys of the identical rather than the
compatible ABO group, and the NOMS data for 1976 suggest that group
A recipients receiving kidneys from group A donors do better than those
receiving kidneys from group 0 donors. However, the 28 group A
patients, despite receiving group A kidneys as their first transplant, did
less well than the 58 group 0 patients (group A 69.2 per cent, group 0
88.6 per cent at one year). The numbers are small and the differences
may well have occurred by chance, but they are in the same direction as
other reports that group 0 recipients have superior graft survival (Joysey,
Roger, Evans and Herbertson, 1973; Opelz and Terasaki, 1977). Opelz
and Terasaki suggested that this might be due to the fact that in general
group 0 patients wait longer on dialysis before receiving their transplant.
This is true of our patients and we have found that patients dialysed for
longer than nine months had better cumulative survival of their first
grafts than those dialysed for less than nine months (93.3 per cent and
71.2 per cent at three months, P>0.01; 85.9 per cent and 69 per cent at
one year, P>0.05). This is in keeping with Opelz and Terasaki's sugges-
tions. The patients who waited longer on dialysis usually received more
blood.
We have satisfactory data on the transfusions received by 69 patients
before the first transplant. Only six did not receive blood but three of
those lost their graft within a few weeks while 57 of the 63 patients
receiving blood have functioning grafts. However, the quantity of blood
did not appear to be important, provided blood was given (Table VI).
95Unfortunately, statistical analysis of these small numbers is not
meaningful.
Rejection clearly accounted for five of the 17 grafts which were lost.
There were five lost from arterial thrombosis, but one of these was
certainly mechanical. Arterial thrombosis is often associated with rejec-
tion (although these four were not typical examples of rejection by any
other criteria) but even if they are considered due to rejection, at most
nine out of the 17 lost grafts were from this cause.
It is clearly important to establish the cause of a rise in plasma urea or
a decline in graft function as these are by no means always due to
rejection. Vascular and ureteric lesions must be considered and we have
found ureteric obstruction an important and frequent cause of late fall
in graft function (Doherty, Douglas and McGeown). It should be remem-
bered that the plasma urea and creatinine rise during acute febrile epi-
sodes and this is not an indication for increasing steroid. There were only
two kidneys with primary non-function although NOHMS data suggest
that about 17 per cent of transplanted kidneys never function.
Meticulous follow-up seems essential so that complications can be
detected and treated promptly.
The survival of our patients treated by cadaveric kidney transplantation
is nearly as good as that claimed for home dialysis and the survival of
grants is well above the European average. The costs of regular dialysis
therapy continue to escalate and we believe that the only hope of pro-
viding treatment for a substantial proportion of those who could benefit
lies in transplantation (McGeown, 1977). The scarcity of kidney donors
continues and we must convince our colleagues that kidney transplanta-
tion is a worthwhile method of treatment capable of returning many to
full health and fitness.
Summary
One hundred kidney transplants have been carried out on 91 patients,
there being seven second transplants and two third transplants. Four
transplants were from living related donors, 96 from cadavers. Seventy-
six patients survive, all but one with functioning kidneys. The cumulative
survival of patients was 82 per cent at two years and 80.7 per cent at five
years. Eight patients died with functioning grafts, and two of the other
deaths occurred more than three months after removal of a rejected
kidney and return to haemodialysis. There were no deaths from sepsis in
the first 60 days after transplantation. The cumulative survival of all
grafts was 82.1 per cent at two and five years. The cumulative survival of
first grafts was 82.5 per cent at two and five years.
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